Versartis Inc. (VSAR) Plummeted To A New Low After Phase 3 Study Failed

Versartis Inc. (VSAR) announced after the close Thursday that its Phase 3 study of somavaratan did not meet its primary endpoint.

from RTT - Before the Bell http://ift.tt/2hrIqHA
via IFTTT